Independent research on the U.S. markets, Baptista Research

Baptista Research

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. 

We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Albertsons Companies' third quarter 2024 results showcase a strategically mixed performance with several growth initiatives balanced by ongoing challenges.</li><li>Despite the termination of the merger, the company continues to execute its Customers for Life strategy, focusing on digital transformation, customer loyalty, and enhancing the overall value proposition.</li><li>Financially, Albertsons reported a 2% increase in identical sales, driven notably by a 13% rise in pharmacy sales and 23% growth in digital sales.</li></ul>

Albertsons Companies' third quarter 2024 results showcase a strategically mixed performance with several growth initiatives balanced by ongoing challenges.Despite the termination of the merger, the company continues to execute its Customers for Life strategy, focusing on digital transformation, customer loyalty, and enhancing the overall value proposition.Financially, Albertsons reported a 2% increase in identical sales, driven notably by a 13% rise in pharmacy sales and 23% growth in digital sales.

アルバートソンズ・カンパニーズ：厳しい競争にもかかわらず、薬局と電子商取引の成長をどのように管理しているのか？

Albertsons Cos

アルバートソンズ・カンパニーズ：厳しい競争にもかかわらず、薬局と電子商取引の成長をどのように管理しているのか？